Report Detail
Global and United States Protein Multiplex Assay Technology Market Report & Forecast 2022-2028
- RnM4374366 |
- 18 January, 2022 |
- Global |
- 124 Pages |
- QYResearch |
- Service & Software
Summary:
Market Analysis and Insights: Global and United States Protein Multiplex Assay Technology Market
This report focuses on global and United States Protein Multiplex Assay Technology market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Protein Multiplex Assay Technology market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, by Type, Consumables accounting for % of the Protein Multiplex Assay Technology global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Pharmaceutical & Biotechnology Companies was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
In United States the Protein Multiplex Assay Technology market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period.
Global Protein Multiplex Assay Technology Scope and Market Size
Protein Multiplex Assay Technology market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Protein Multiplex Assay Technology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Protein Multiplex Assay Technology market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type, the Protein Multiplex Assay Technology market is segmented into
Consumables
Instruments
Software & Services
Segment by Application, the Protein Multiplex Assay Technology market is segmented into
Pharmaceutical & Biotechnology Companies
Hospitals & Research Institutes
Reference Laboratories
Other
Regional and Country-level Analysis
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Competitive Landscape and Protein Multiplex Assay Technology Market Share Analysis
Protein Multiplex Assay Technology market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Protein Multiplex Assay Technology business, the date to enter into the Protein Multiplex Assay Technology market, Revenue in Protein Multiplex Assay Technology Business (2017-2022) & (US$ Million) introduction, recent developments, etc.
The major vendors covered:
Luminex Corporation (US)
Thermo Fisher Scientific Inc. (US)
Illumina, Inc (US)
Bio-Rad Laboratories, Inc. (US)
Qiagen N.V. (Netherlands)
Abcam plc (UK)
Becton, Dickinson and Company (US)
Merck KGaA (Germany)
Agilent Technologies, Inc. (US)
Meso Scale Diagnostics (US)
Randox Laboratories (UK)
Quanterix (US)
Bio-Techne Corporation (US)
Olink (Sweden)
DiaSorin S.p.A. (Italy)
Seegene (South Korea)
Promega Corporation (US)
Siemens Healthineers (Germany)
PerkinElmer, Inc. (US)
Shimadzu Biotech (Japan)
Antigenix America, Inc. (US)
Enzo Life Sciences, Inc. (US)
Boster Biological Technology (US)
AYOXXA Biosystems GmbH (Germany)
Cayman Chemical Company (US)
Table of Contents
1 Study Coverage
- 1.1 Protein Multiplex Assay Technology Revenue in Protein Multiplex Assay Technology Business (2017-2022) & (US$ Million) Introduction
- 1.2 Global Protein Multiplex Assay Technology Outlook 2017 VS 2022 VS 2028
- 1.2.1 Global Protein Multiplex Assay Technology Market Size for the Year 2017-2028
- 1.2.2 Global Protein Multiplex Assay Technology Market Size for the Year 2017-2028
- 1.3 Protein Multiplex Assay Technology Market Size, United States VS Global, 2017 VS 2022 VS 2028
- 1.3.1 The Market Share of United States Protein Multiplex Assay Technology in Global, 2017 VS 2022 VS 2028
- 1.3.2 The Growth Rate of Protein Multiplex Assay Technology Market Size, United States VS Global, 2017 VS 2022 VS 2028
- 1.4 Protein Multiplex Assay Technology Market Dynamics
- 1.4.1 Protein Multiplex Assay Technology Industry Trends
- 1.4.2 Protein Multiplex Assay Technology Market Drivers
- 1.4.3 Protein Multiplex Assay Technology Market Challenges
- 1.4.4 Protein Multiplex Assay Technology Market Restraints
- 1.5 Study Objectives
- 1.6 Years Considered
2 Protein Multiplex Assay Technology by Type
- 2.1 Protein Multiplex Assay Technology Market Segment by Type
- 2.1.1 Consumables
- 2.1.2 Instruments
- 2.1.3 Software & Services
- 2.2 Global Protein Multiplex Assay Technology Market Size by Type (2017, 2022 & 2028)
- 2.3 Global Protein Multiplex Assay Technology Market Size by Type (2017-2028)
- 2.4 United States Protein Multiplex Assay Technology Market Size by Type (2017, 2022 & 2028)
- 2.5 United States Protein Multiplex Assay Technology Market Size by Type (2017-2028)
3 Protein Multiplex Assay Technology by Application
- 3.1 Protein Multiplex Assay Technology Market Segment by Application
- 3.1.1 Pharmaceutical & Biotechnology Companies
- 3.1.2 Hospitals & Research Institutes
- 3.1.3 Reference Laboratories
- 3.1.4 Other
- 3.2 Global Protein Multiplex Assay Technology Market Size by Application (2017, 2022 & 2028)
- 3.3 Global Protein Multiplex Assay Technology Market Size by Application (2017-2028)
- 3.4 United States Protein Multiplex Assay Technology Market Size by Application (2017, 2022 & 2028)
- 3.5 United States Protein Multiplex Assay Technology Market Size by Application (2017-2028)
4 Global Protein Multiplex Assay Technology Competitor Landscape by Company
- 4.1 Global Protein Multiplex Assay Technology Market Size by Company
- 4.1.1 Top Global Protein Multiplex Assay Technology Companies Ranked by Revenue (2021)
- 4.1.2 Global Protein Multiplex Assay Technology Revenue by Player (2017-2022)
- 4.2 Global Protein Multiplex Assay Technology Concentration Ratio (CR)
- 4.2.1 Protein Multiplex Assay Technology Market Concentration Ratio (CR) (2017-2022)
- 4.2.2 Global Top 5 and Top 10 Largest Companies of Protein Multiplex Assay Technology in 2021
- 4.2.3 Global Protein Multiplex Assay Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 4.3 Global Protein Multiplex Assay Technology Headquarters, Revenue in Protein Multiplex Assay Technology Business (2017-2022) & (US$ Million) Type
- 4.3.1 Global Protein Multiplex Assay Technology Headquarters and Area Served
- 4.3.2 Global Protein Multiplex Assay Technology Companies Revenue in Protein Multiplex Assay Technology Business (2017-2022) & (US$ Million) Type
- 4.3.3 Date of International Companies Enter into Protein Multiplex Assay Technology Market
- 4.4 Companies Mergers & Acquisitions, Expansion Plans
- 4.5 United States Protein Multiplex Assay Technology Market Size by Company
- 4.5.1 Top Protein Multiplex Assay Technology Players in United States, Ranked by Revenue (2021)
- 4.5.2 United States Protein Multiplex Assay Technology Revenue by Players (2020, 2021 & 2022)
5 Global Protein Multiplex Assay Technology Market Size by Region
- 5.1 Global Protein Multiplex Assay Technology Market Size by Region: 2017 VS 2022 VS 2028
- 5.2 Global Protein Multiplex Assay Technology Market Size by Region (2017-2028)
- 5.2.1 Global Protein Multiplex Assay Technology Market Size by Region: 2017-2022
- 5.2.2 Global Protein Multiplex Assay Technology Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
- 6.1 North America
- 6.1.1 North America Protein Multiplex Assay Technology Market Size YoY Growth 2017-2028
- 6.1.2 North America Protein Multiplex Assay Technology Market Facts & Figures by Country (2017, 2022 & 2028)
- 6.1.3 United States
- 6.1.4 Canada
- 6.2 Asia-Pacific
- 6.2.1 Asia-Pacific Protein Multiplex Assay Technology Market Size YoY Growth 2017-2028
- 6.2.2 Asia-Pacific Protein Multiplex Assay Technology Market Facts & Figures by Region (2017, 2022 & 2028)
- 6.2.3 China
- 6.2.4 Japan
- 6.2.5 South Korea
- 6.2.6 India
- 6.2.7 Australia
- 6.2.8 China Taiwan
- 6.2.9 Indonesia
- 6.2.10 Thailand
- 6.2.11 Malaysia
- 6.3 Europe
- 6.3.1 Europe Protein Multiplex Assay Technology Market Size YoY Growth 2017-2028
- 6.3.2 Europe Protein Multiplex Assay Technology Market Facts & Figures by Country (2017, 2022 & 2028)
- 6.3.3 Germany
- 6.3.4 France
- 6.3.5 U.K.
- 6.3.6 Italy
- 6.3.7 Russia
- 6.4 Latin America
- 6.4.1 Latin America Protein Multiplex Assay Technology Market Size YoY Growth 2017-2028
- 6.4.2 Latin America Protein Multiplex Assay Technology Market Facts & Figures by Country (2017, 2022 & 2028)
- 6.4.3 Mexico
- 6.4.4 Brazil
- 6.4.5 Argentina
- 6.4.6 Colombia
- 6.5 Middle East and Africa
- 6.5.1 Middle East and Africa Protein Multiplex Assay Technology Market Size YoY Growth 2017-2028
- 6.5.2 Middle East and Africa Protein Multiplex Assay Technology Market Facts & Figures by Country (2017, 2022 & 2028)
- 6.5.3 Turkey
- 6.5.4 Saudi Arabia
- 6.5.5 UAE
7 Company Profiles
- 7.1 Luminex Corporation (US)
- 7.1.1 Luminex Corporation (US) Company Details
- 7.1.2 Luminex Corporation (US) Business Overview
- 7.1.3 Luminex Corporation (US) Protein Multiplex Assay Technology Introduction
- 7.1.4 Luminex Corporation (US) Revenue in Protein Multiplex Assay Technology Business (2017-2022)
- 7.1.5 Luminex Corporation (US) Recent Development
- 7.2 Thermo Fisher Scientific Inc. (US)
- 7.2.1 Thermo Fisher Scientific Inc. (US) Company Details
- 7.2.2 Thermo Fisher Scientific Inc. (US) Business Overview
- 7.2.3 Thermo Fisher Scientific Inc. (US) Protein Multiplex Assay Technology Introduction
- 7.2.4 Thermo Fisher Scientific Inc. (US) Revenue in Protein Multiplex Assay Technology Business (2017-2022)
- 7.2.5 Thermo Fisher Scientific Inc. (US) Recent Development
- 7.3 Illumina, Inc (US)
- 7.3.1 Illumina, Inc (US) Company Details
- 7.3.2 Illumina, Inc (US) Business Overview
- 7.3.3 Illumina, Inc (US) Protein Multiplex Assay Technology Introduction
- 7.3.4 Illumina, Inc (US) Revenue in Protein Multiplex Assay Technology Business (2017-2022)
- 7.3.5 Illumina, Inc (US) Recent Development
- 7.4 Bio-Rad Laboratories, Inc. (US)
- 7.4.1 Bio-Rad Laboratories, Inc. (US) Company Details
- 7.4.2 Bio-Rad Laboratories, Inc. (US) Business Overview
- 7.4.3 Bio-Rad Laboratories, Inc. (US) Protein Multiplex Assay Technology Introduction
- 7.4.4 Bio-Rad Laboratories, Inc. (US) Revenue in Protein Multiplex Assay Technology Business (2017-2022)
- 7.4.5 Bio-Rad Laboratories, Inc. (US) Recent Development
- 7.5 Qiagen N.V. (Netherlands)
- 7.5.1 Qiagen N.V. (Netherlands) Company Details
- 7.5.2 Qiagen N.V. (Netherlands) Business Overview
- 7.5.3 Qiagen N.V. (Netherlands) Protein Multiplex Assay Technology Introduction
- 7.5.4 Qiagen N.V. (Netherlands) Revenue in Protein Multiplex Assay Technology Business (2017-2022)
- 7.5.5 Qiagen N.V. (Netherlands) Recent Development
- 7.6 Abcam plc (UK)
- 7.6.1 Abcam plc (UK) Company Details
- 7.6.2 Abcam plc (UK) Business Overview
- 7.6.3 Abcam plc (UK) Protein Multiplex Assay Technology Introduction
- 7.6.4 Abcam plc (UK) Revenue in Protein Multiplex Assay Technology Business (2017-2022)
- 7.6.5 Abcam plc (UK) Recent Development
- 7.7 Becton, Dickinson and Company (US)
- 7.7.1 Becton, Dickinson and Company (US) Company Details
- 7.7.2 Becton, Dickinson and Company (US) Business Overview
- 7.7.3 Becton, Dickinson and Company (US) Protein Multiplex Assay Technology Introduction
- 7.7.4 Becton, Dickinson and Company (US) Revenue in Protein Multiplex Assay Technology Business (2017-2022)
- 7.7.5 Becton, Dickinson and Company (US) Recent Development
- 7.8 Merck KGaA (Germany)
- 7.8.1 Merck KGaA (Germany) Company Details
- 7.8.2 Merck KGaA (Germany) Business Overview
- 7.8.3 Merck KGaA (Germany) Protein Multiplex Assay Technology Introduction
- 7.8.4 Merck KGaA (Germany) Revenue in Protein Multiplex Assay Technology Business (2017-2022)
- 7.8.5 Merck KGaA (Germany) Recent Development
- 7.9 Agilent Technologies, Inc. (US)
- 7.9.1 Agilent Technologies, Inc. (US) Company Details
- 7.9.2 Agilent Technologies, Inc. (US) Business Overview
- 7.9.3 Agilent Technologies, Inc. (US) Protein Multiplex Assay Technology Introduction
- 7.9.4 Agilent Technologies, Inc. (US) Revenue in Protein Multiplex Assay Technology Business (2017-2022)
- 7.9.5 Agilent Technologies, Inc. (US) Recent Development
- 7.10 Meso Scale Diagnostics (US)
- 7.10.1 Meso Scale Diagnostics (US) Company Details
- 7.10.2 Meso Scale Diagnostics (US) Business Overview
- 7.10.3 Meso Scale Diagnostics (US) Protein Multiplex Assay Technology Introduction
- 7.10.4 Meso Scale Diagnostics (US) Revenue in Protein Multiplex Assay Technology Business (2017-2022)
- 7.10.5 Meso Scale Diagnostics (US) Recent Development
- 7.11 Randox Laboratories (UK)
- 7.11.1 Randox Laboratories (UK) Company Details
- 7.11.2 Randox Laboratories (UK) Business Overview
- 7.11.3 Randox Laboratories (UK) Protein Multiplex Assay Technology Introduction
- 7.11.4 Randox Laboratories (UK) Revenue in Protein Multiplex Assay Technology Business (2017-2022)
- 7.11.5 Randox Laboratories (UK) Recent Development
- 7.12 Quanterix (US)
- 7.12.1 Quanterix (US) Company Details
- 7.12.2 Quanterix (US) Business Overview
- 7.12.3 Quanterix (US) Protein Multiplex Assay Technology Introduction
- 7.12.4 Quanterix (US) Revenue in Protein Multiplex Assay Technology Business (2017-2022)
- 7.12.5 Quanterix (US) Recent Development
- 7.13 Bio-Techne Corporation (US)
- 7.13.1 Bio-Techne Corporation (US) Company Details
- 7.13.2 Bio-Techne Corporation (US) Business Overview
- 7.13.3 Bio-Techne Corporation (US) Protein Multiplex Assay Technology Introduction
- 7.13.4 Bio-Techne Corporation (US) Revenue in Protein Multiplex Assay Technology Business (2017-2022)
- 7.13.5 Bio-Techne Corporation (US) Recent Development
- 7.14 Olink (Sweden)
- 7.14.1 Olink (Sweden) Company Details
- 7.14.2 Olink (Sweden) Business Overview
- 7.14.3 Olink (Sweden) Protein Multiplex Assay Technology Introduction
- 7.14.4 Olink (Sweden) Revenue in Protein Multiplex Assay Technology Business (2017-2022)
- 7.14.5 Olink (Sweden) Recent Development
- 7.15 DiaSorin S.p.A. (Italy)
- 7.15.1 DiaSorin S.p.A. (Italy) Company Details
- 7.15.2 DiaSorin S.p.A. (Italy) Business Overview
- 7.15.3 DiaSorin S.p.A. (Italy) Protein Multiplex Assay Technology Introduction
- 7.15.4 DiaSorin S.p.A. (Italy) Revenue in Protein Multiplex Assay Technology Business (2017-2022)
- 7.15.5 DiaSorin S.p.A. (Italy) Recent Development
- 7.16 Seegene (South Korea)
- 7.16.1 Seegene (South Korea) Company Details
- 7.16.2 Seegene (South Korea) Business Overview
- 7.16.3 Seegene (South Korea) Protein Multiplex Assay Technology Introduction
- 7.16.4 Seegene (South Korea) Revenue in Protein Multiplex Assay Technology Business (2017-2022)
- 7.16.5 Seegene (South Korea) Recent Development
- 7.17 Promega Corporation (US)
- 7.17.1 Promega Corporation (US) Company Details
- 7.17.2 Promega Corporation (US) Business Overview
- 7.17.3 Promega Corporation (US) Protein Multiplex Assay Technology Introduction
- 7.17.4 Promega Corporation (US) Revenue in Protein Multiplex Assay Technology Business (2017-2022)
- 7.17.5 Promega Corporation (US) Recent Development
- 7.18 Siemens Healthineers (Germany)
- 7.18.1 Siemens Healthineers (Germany) Company Details
- 7.18.2 Siemens Healthineers (Germany) Business Overview
- 7.18.3 Siemens Healthineers (Germany) Protein Multiplex Assay Technology Introduction
- 7.18.4 Siemens Healthineers (Germany) Revenue in Protein Multiplex Assay Technology Business (2017-2022)
- 7.18.5 Siemens Healthineers (Germany) Recent Development
- 7.19 PerkinElmer, Inc. (US)
- 7.19.1 PerkinElmer, Inc. (US) Company Details
- 7.19.2 PerkinElmer, Inc. (US) Business Overview
- 7.19.3 PerkinElmer, Inc. (US) Protein Multiplex Assay Technology Introduction
- 7.19.4 PerkinElmer, Inc. (US) Revenue in Protein Multiplex Assay Technology Business (2017-2022)
- 7.19.5 PerkinElmer, Inc. (US) Recent Development
- 7.20 Shimadzu Biotech (Japan)
- 7.20.1 Shimadzu Biotech (Japan) Company Details
- 7.20.2 Shimadzu Biotech (Japan) Business Overview
- 7.20.3 Shimadzu Biotech (Japan) Protein Multiplex Assay Technology Introduction
- 7.20.4 Shimadzu Biotech (Japan) Revenue in Protein Multiplex Assay Technology Business (2017-2022)
- 7.20.5 Shimadzu Biotech (Japan) Recent Development
- 7.21 Antigenix America, Inc. (US)
- 7.21.1 Antigenix America, Inc. (US) Company Details
- 7.21.2 Antigenix America, Inc. (US) Business Overview
- 7.21.3 Antigenix America, Inc. (US) Protein Multiplex Assay Technology Introduction
- 7.21.4 Antigenix America, Inc. (US) Revenue in Protein Multiplex Assay Technology Business (2017-2022)
- 7.21.5 Antigenix America, Inc. (US) Recent Development
- 7.22 Enzo Life Sciences, Inc. (US)
- 7.22.1 Enzo Life Sciences, Inc. (US) Company Details
- 7.22.2 Enzo Life Sciences, Inc. (US) Business Overview
- 7.22.3 Enzo Life Sciences, Inc. (US) Protein Multiplex Assay Technology Introduction
- 7.22.4 Enzo Life Sciences, Inc. (US) Revenue in Protein Multiplex Assay Technology Business (2017-2022)
- 7.22.5 Enzo Life Sciences, Inc. (US) Recent Development
- 7.23 Boster Biological Technology (US)
- 7.23.1 Boster Biological Technology (US) Company Details
- 7.23.2 Boster Biological Technology (US) Business Overview
- 7.23.3 Boster Biological Technology (US) Protein Multiplex Assay Technology Introduction
- 7.23.4 Boster Biological Technology (US) Revenue in Protein Multiplex Assay Technology Business (2017-2022)
- 7.23.5 Boster Biological Technology (US) Recent Development
- 7.24 AYOXXA Biosystems GmbH (Germany)
- 7.24.1 AYOXXA Biosystems GmbH (Germany) Company Details
- 7.24.2 AYOXXA Biosystems GmbH (Germany) Business Overview
- 7.24.3 AYOXXA Biosystems GmbH (Germany) Protein Multiplex Assay Technology Introduction
- 7.24.4 AYOXXA Biosystems GmbH (Germany) Revenue in Protein Multiplex Assay Technology Business (2017-2022)
- 7.24.5 AYOXXA Biosystems GmbH (Germany) Recent Development
- 7.25 Cayman Chemical Company (US)
- 7.25.1 Cayman Chemical Company (US) Company Details
- 7.25.2 Cayman Chemical Company (US) Business Overview
- 7.25.3 Cayman Chemical Company (US) Protein Multiplex Assay Technology Introduction
- 7.25.4 Cayman Chemical Company (US) Revenue in Protein Multiplex Assay Technology Business (2017-2022)
- 7.25.5 Cayman Chemical Company (US) Recent Development
8 Research Findings and Conclusion
9 Appendix
- 9.1 Research Methodology
- 9.1.1 Methodology/Research Approach
- 9.1.2 Data Source
- 9.2 Author Details
Summary:
Get latest Market Research Reports on Protein Multiplex Assay Technology. Industry analysis & Market Report on Protein Multiplex Assay Technology is a syndicated market report, published as Global and United States Protein Multiplex Assay Technology Market Report & Forecast 2022-2028. It is complete Research Study and Industry Analysis of Protein Multiplex Assay Technology market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
